Industry News
Latest orthopaedic industry news on orthopaedic companies, devices, implants & technology trends.
- Written by Editor-in-Chief
- Category: Industry News
The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due to increasing demand for minimally invasive surgical procedures among patients and development of technologically advanced non-fusion devices. The massive unexplored market in the spinal implants and spinal devices industry of the developing economies is creating abundant growth opportunities for the global spinal implants and spinal devices surgery market.
- Written by Editor-in-Chief
- Category: Industry News
Dallas, TX, February 18, 2017 --(PR.com)-- The Global medical aesthetics market is expected to reach USD 16.1 billion by 2024 from USD 8.33 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. The global medical aesthetic devices market is segmented on the basis of product type, application, end-user, distribution channel and geography. On the basis of product type the market is segmented into Aesthetic Laser devices which is further sub divided into Fractional Carbon Dioxide Laser Resurfacing, Ablative Skin Resurfacing Devices, Non-Ablative Fractional Laser Skin Resurfacing; Energy Devices which is further segmented into Electrocautery, Electrosurgery, Cryosurgery, Laser surgery, Microwave, Harmonic scalpel.
- Written by Sirakoss
- Category: Industry News
SIRAKOSS Ltd., a UK-based medical device company developing innovative bone grafting solutions for the $3 billion global orthopaedic market, has announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its bone graft technologies. SIRAKOSS‘ patent portfolio encompasses advanced synthetic bone graft technologies which form the company’s product pipeline designed to address the significant clinical need for a fully-synthetic, standalone bone void filler. SIRAKOSS’ technologies provide consistently effective bone regeneration without the established risks found by using either autograft or therapeutics-based products such as BMP’s.
- Written by Editor-in-Chief
- Category: Industry News
Here's how to take on the challenge of selecting the right materials for an implantable medical device. Len Czuba I don’t think that there is any challenge more confusing to product development teams than selecting materials that can be used for long-term implantable medical devices. Are there databases where implantable materials are featured? Can we go to our local supplier and ask them to recommend a material that can be used for implant applications? Usually the answer to both questions is “No." There are not databases that offer a variety of implantable materials like produce at a supermarket, nor would they be accurate if they did exist.
- Written by Editor-in-Chief
- Category: Industry News
The report “Global Hearing Aid Market” provides an in-depth analysis of the global market along with markets of the US and Europe. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The industry comprises few large players such as Sonova, William Demant and GN Re Sound. All these companies have been profiled in the present report highlighting their key financials and business strategies for growth. Purchase a copy of this report at http://www.marketreportsonline.com/contacts/purchase.php?name=504970. Hearing aid market is an emerging healthcare market due to introduction of various innovations and dynamics.
- Written by Editor-in-Chief
- Category: Industry News
I can't but agree to the positive statements about your portal: easy to use, clear layout, very good search function, and quick editing! Jens O'Brien, Borgmeier Media Communication
- Written by Editor-in-Chief
- Category: Industry News
Details from the Promimic announcement follow: Magnus Larsson has a solid background in Sales and Marketing, having held a number of leadership positions in the international dental implant industry over the last 15 years. Most recently he was Director, Global Market Development, at Dentsply Sirona Implants, Mölndal, Sweden. Former CEO Ulf Brogren is relocating to the US to launch Promimic Inc.’s new North American sales operations in Austin, Texas. This new commercial operation is aimed bringing Promimic closer to the market and to its customer base in North America, the largest market for orthopedic and dental implants.
- Written by mwood@beckershealthcare.com (Megan Wood)
- Category: Industry News
Here are five things to know: 1. The University of New Mexico Hospital is the state's sole Level 1 trauma center. 2. Jeremy Lewis, MD, an assistant neurosurgery professor, will serve as principal investigator. 3. Dr. Lewis completed his complex cranial and skull base surgery fellowship at University of Texas Southwestern in Dallas. 4. The University of New Mexico Hospital joins 29 other clinical sites participating in the INSPIRE study. 5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
- Written by Editor-in-Chief
- Category: Industry News
Platelet rich plasma (PRP) market has witnessed appreciable growth due to a growing number of devices being FDA approved in recent years; however the therapeutics market is anticipated to have an uncertain future, even as non-approved therapeutic applications flourish. Although various platelet rich plasma isolation devices have received 510(k) clearance, platelet rich plasma has not been approved for direct injection or implant without prior mixing with the bone graft materials. Following types of plate rich plasma (PRP) preparations are currently available in the market:Leukocyte-poor or pure PRPLeukocyte PRPPure platelet-rich fibrin clotLeukocyte platelet-rich fibrin clotFree Sample Report@ http://www.sa-brc.com/Global-Platelet-Rich-Plasma-PRP-Market-Assessment–Forecast-2016-2020/up54 In spite of non-regulatory approval, PRP has been widely used in sports medicine.
- Written by Editor-in-Chief
- Category: Industry News
President Barack Obama’s $1 billion commitment to make American manufacturing more competitive took another step forward Friday when Carnegie Mellon University and the U.S. Department of Defense announced plans for a $253 million robotics research initiative based in Pittsburgh. The center — funded by 220 government, industry and academic sources — is the latest of 14 manufacturing institutes that are researching technologies like 3-D printing medical implants that will help broken bones heal faster; working on new, streamlined ways of manufacturing lightweight metals; and developing breakthrough fabrics capable of storing energy and monitoring the health of the person who wears them.
Submit Community Content
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!